News

AddToAny

Google+ Facebook Twitter Twitter

Novel Covid test

A new rapid test has been developed that is 98.3% accurate for positive COVID-19 tests and 96% for negative tests.

The novel COVID-19 test uses a mass spectrometer, which is paired with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs.

The mass spectrometer can analyse samples in minutes, with the entire process taking a total of about 20 minutes.

The accuracy matches or outperforms many of the current COVID-19 screening tests, it is claimed.

The new testing method may allow for the rapid screening of large numbers of individuals for businesses, schools, venues and other large facilities.

This is the first test for COVID-19 that pairs mass spectrometry with robotics and a robust automated machine-learning platform to rapidly deliver test results.

The coupling of these unique elements not only allows testing for COVID-19, but may be able to quickly adapt to detect other diseases and perhaps future pandemic organisms.

go.nature.com/3e8pGb9

Image credit | iStock

Related Articles

All-in-one Covid surveillance test

A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses, it is claimed.

Ultra-sensitive rapid diagnostic for Ebola

An interdisciplinary team of scientists has developed a highly sensitive and rapid diagnostic test for Ebola virus (EBOV) infection.

Focus on... autosomal dominant polycystic kidney disease

Kamila Orzechowska, a final-year student at Coventry University, looks at the role of epidermal growth factor receptors and microbial infections in autosomal dominant polycystic kidney disease.

Top